NexturnBioscience Co. Ltd Cash Flow Conversion Efficiency
NexturnBioscience Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, NexturnBioscience Co. Ltd (089140) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.51 Billion ≈ $3.06 Million USD) by net assets (₩240.26 Billion ≈ $162.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of NexturnBioscience Co. Ltd (2014–2024)
Cash flow conversion efficiency of NexturnBioscience Co. Ltd from 2014 to 2024. This chart illustrates how NexturnBioscience Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NexturnBioscience Co. Ltd (089140) stock price for real-time trading data and today's change.
NexturnBioscience Co. Ltd Cash Flow Conversion Ratio Explained
NexturnBioscience Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
NexturnBioscience Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NexturnBioscience Co. Ltd ranked by their cash flow conversion efficiency. Also see NexturnBioscience Co. Ltd (089140) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Europa Metals Ltd
JSE:EUZ
|
-0.110x |
|
Ark Mines Ltd
AU:AHK
|
-0.048x |
|
Vaswani Industries Limited
NSE:VASWANI
|
0.072x |
|
Artroniq Berhad
KLSE:0038
|
0.001x |
|
Korea Information Engineering Services Co. Ltd
KQ:039740
|
0.290x |
|
Good Times Restaurants Inc
NASDAQ:GTIM
|
0.049x |
|
Akritas S.A
AT:AKRIT
|
-0.137x |
|
Talex S.A.
WAR:TLX
|
0.007x |
Annual Cash Flow Conversion Efficiency for NexturnBioscience Co. Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of NexturnBioscience Co. Ltd from 2014 to 2024. Review NexturnBioscience Co. Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩136.62 Billion ≈ $92.59 Million |
₩-1.14 Billion ≈ $-774.60K |
-0.008x | +41.40% |
| 2023-12-31 | ₩138.01 Billion ≈ $93.53 Million |
₩-1.97 Billion ≈ $-1.34 Million |
-0.014x | -29.82% |
| 2022-12-31 | ₩108.27 Billion ≈ $73.38 Million |
₩-1.19 Billion ≈ $-806.98K |
-0.011x | -127.83% |
| 2021-12-31 | ₩92.73 Billion ≈ $62.85 Million |
₩3.66 Billion ≈ $2.48 Million |
0.040x | +1520.67% |
| 2020-12-31 | ₩96.77 Billion ≈ $65.58 Million |
₩235.94 Million ≈ $159.89K |
0.002x | -91.07% |
| 2019-12-31 | ₩100.16 Billion ≈ $67.88 Million |
₩2.74 Billion ≈ $1.85 Million |
0.027x | -72.91% |
| 2018-12-31 | ₩95.51 Billion ≈ $64.73 Million |
₩9.63 Billion ≈ $6.52 Million |
0.101x | +81.94% |
| 2017-12-31 | ₩91.77 Billion ≈ $62.19 Million |
₩5.08 Billion ≈ $3.45 Million |
0.055x | -72.15% |
| 2016-12-31 | ₩89.89 Billion ≈ $60.92 Million |
₩17.88 Billion ≈ $12.12 Million |
0.199x | +211.78% |
| 2015-12-31 | ₩30.04 Billion ≈ $20.36 Million |
₩1.92 Billion ≈ $1.30 Million |
0.064x | -71.37% |
| 2014-12-31 | ₩29.08 Billion ≈ $19.70 Million |
₩6.48 Billion ≈ $4.39 Million |
0.223x | -- |
About NexturnBioscience Co. Ltd
Nexturn Co.,Ltd. develops and produces CNC automatic lathe machines in Korea and internationally. It provides CNC swiss-type automatic lathe products, high temperature display glass press equipment, and automatic line-up robots, as well as an intelligent intervention robot system based on robot 3D cardiovascular visualization technology. The company was formerly known as KMT Incorporated and chan… Read more